Explore more publications!
Educators Post Observer
Got News to Share?

Press Releases

Ascentage Pharma Presents Pivotal China Registrational Study Data for Lisaftoclax in Oral Report at 2025 American Society of Hematology (ASH) Annual Meeting
December 6, 2025

Ascentage Pharma Presents Pivotal China Registrational Study Data for Lisaftoclax in Oral Report at 2025 American Society of Hematology (ASH) Annual Meeting

Indeterminate GlobeNewswire, Inc.
Bicara Therapeutics’ Preliminary Phase 1b Expansion Cohort Data Evaluating 750mg of Ficerafusp Alfa Weekly Plus Pembrolizumab Advances Pivotal Study Dose Selection on Track for First Quarter 2026
December 6, 2025

Bicara Therapeutics’ Preliminary Phase 1b Expansion Cohort Data Evaluating 750mg of Ficerafusp Alfa Weekly Plus Pembrolizumab Advances Pivotal Study Dose Selection on Track for First Quarter 2026

Indeterminate GlobeNewswire, Inc.
The Greene School Students Begin Two-Year Journey: Assembly of RV-12 Aircraft Underway
December 5, 2025

The Greene School Students Begin Two-Year Journey: Assembly of RV-12 Aircraft Underway

Neutral EIN Presswire
New School Performance Information Available, North Dakota Schools Show Meaningful Gains in Choice Ready, Graduation Rates
December 5, 2025

New School Performance Information Available, North Dakota Schools Show Meaningful Gains in Choice Ready, Graduation Rates

Gov't Institution North Dakota Department of Public Instruction
Owner: American Government

North Dakota Department of Public Instruction

Gov't Institution
Owned By American Government
Year Founded 1863
Website www.nd.gov
Domain Registration Year Indeterminate
Access Type open
Publication Location United States, North Dakota, Bismarck
Owner Country United States

We welcome your feedback!
If you have comments or corrections, let us know.

New School Performance Information Available, North Dakota Schools Show Meaningful Gains in Choice Ready, Graduation Rates
December 5, 2025

New School Performance Information Available, North Dakota Schools Show Meaningful Gains in Choice Ready, Graduation Rates

Gov't Institution North Dakota Department of Public Instruction
Owner: American Government

North Dakota Department of Public Instruction

Gov't Institution
Owned By American Government
Year Founded 1863
Website www.nd.gov
Domain Registration Year Indeterminate
Access Type open
Publication Location United States, North Dakota, Bismarck
Owner Country United States

We welcome your feedback!
If you have comments or corrections, let us know.

Aerospace Materials Market Size, Share & Trends Analysis Report 2026- 2035
December 5, 2025

Aerospace Materials Market Size, Share & Trends Analysis Report 2026- 2035

Indeterminate GlobeNewswire, Inc.
Gelteq Preclinical Study Demonstrates Enhanced Oral Delivery of Oil-Soluble and Poorly Soluble Drugs Using Its Gel-Based Platform
December 5, 2025

Gelteq Preclinical Study Demonstrates Enhanced Oral Delivery of Oil-Soluble and Poorly Soluble Drugs Using Its Gel-Based Platform

Indeterminate GlobeNewswire, Inc.
From Ancestry to Artistry: Mezzanine Gallery presents Renita Coursey’s “The Garden”
December 5, 2025

From Ancestry to Artistry: Mezzanine Gallery presents Renita Coursey’s “The Garden”

Gov't Institution Division of Community Affairs - Delaware
Owner: American Government

Division of Community Affairs - Delaware

Gov't Institution
Owned By American Government
Year Founded Indeterminate
Website news.delaware.gov
Domain Registration Year Indeterminate
Access Type open
Publication Location United States, Delaware, Dover
Owner Country United States

We welcome your feedback!
If you have comments or corrections, let us know.

Accendatech US comments on the recent setback in phase 2 study to evaluate STAT3 as therapeutic target and other drug development strategies such as AI and precision medicine to treat patients with IPF
December 5, 2025

Accendatech US comments on the recent setback in phase 2 study to evaluate STAT3 as therapeutic target and other drug development strategies such as AI and precision medicine to treat patients with IPF

Indeterminate GlobeNewswire, Inc.
Xenon Showcases New 48-Month Azetukalner OLE Study Data in Epilepsy at AES 2025
December 5, 2025

Xenon Showcases New 48-Month Azetukalner OLE Study Data in Epilepsy at AES 2025

Indeterminate GlobeNewswire, Inc.
Biomea Fusion Presents COVALENT-111 Study Results at the 23rd World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC)
December 5, 2025

Biomea Fusion Presents COVALENT-111 Study Results at the 23rd World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC)

Indeterminate GlobeNewswire, Inc.
Peer Reviewed Study Highlights Therapeutic Potential Around Application of Stromal Cell Therapies Such as INmune Bio’s CORDStrom™ Platform
December 5, 2025

Peer Reviewed Study Highlights Therapeutic Potential Around Application of Stromal Cell Therapies Such as INmune Bio’s CORDStrom™ Platform

Indeterminate GlobeNewswire, Inc.
Dr. Garcia Announces Holiday Gift Discount and Flexible Payment Plans for Biomagnetism Online Training
December 6, 2025

Dr. Garcia Announces Holiday Gift Discount and Flexible Payment Plans for Biomagnetism Online Training

Neutral EIN Presswire
Ascentage Pharma Announces Global Registrational Phase III Study of Olverembatinib in First-Line Treatment of Ph+ ALL Cleared by US FDA and EMA
December 5, 2025

Ascentage Pharma Announces Global Registrational Phase III Study of Olverembatinib in First-Line Treatment of Ph+ ALL Cleared by US FDA and EMA

Indeterminate GlobeNewswire, Inc.
Praxis Precision Medicines Announces Positive Results from EMBOLD Study for Relutrigine in SCN2A and SCN8A Developmental and Epileptic Encephalopathies
December 4, 2025

Praxis Precision Medicines Announces Positive Results from EMBOLD Study for Relutrigine in SCN2A and SCN8A Developmental and Epileptic Encephalopathies

Indeterminate GlobeNewswire, Inc.
Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
December 4, 2025

Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025

Indeterminate GlobeNewswire, Inc.
Registration Open for School-Based Behavioral Health ECHO© Series
December 4, 2025

Registration Open for School-Based Behavioral Health ECHO© Series

Gov't Institution Maine Department of Education
Owner: American Government

Maine Department of Education

Gov't Institution
Owned By American Government
Year Founded 2008
Website https://mainedoenews.net/
Domain Registration Year 2011
Access Type open
Publication Location United States, Maine, Augusta
Owner Country United States

We welcome your feedback!
If you have comments or corrections, let us know.

Sustainability Day Summit: From Global Low-Carbon Systems to Student Impact
December 4, 2025

Sustainability Day Summit: From Global Low-Carbon Systems to Student Impact

Neutral EIN Presswire
This Week in Construction: Top News, Blogs, Case Studies, Videos & Industry Trends – December 4, 2025
December 4, 2025

This Week in Construction: Top News, Blogs, Case Studies, Videos & Industry Trends – December 4, 2025

Neutral EIN Presswire
The Ritz-Carlton Leadership Center Announces Two Live Virtual Courses Designed to Elevate Service Outcomes in 2026
December 4, 2025

The Ritz-Carlton Leadership Center Announces Two Live Virtual Courses Designed to Elevate Service Outcomes in 2026

Neutral EIN Presswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions